These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8571293)

  • 21. [Hypertrichosis caused by minoxidil].
    Ryckmanns F
    Hautarzt; 1980 Apr; 31(4):205-6. PubMed ID: 7399913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fluffy hypertrichosis induced by minoxidil].
    Pierard GE; Letot B; Henry C
    Dermatologica; 1979; 158(3):175-7. PubMed ID: 446820
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypertrichosis during treatment with minoxidil].
    Bencini PL; Crosti C; Ambroso GC; Sala F; Povia T
    G Ital Dermatol Venereol; 1985; 120(2):137-40. PubMed ID: 4007956
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
    Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Fernandez-Nieto D; Vaño-Galvan S
    J Am Acad Dermatol; 2019 Aug; 81(2):648-649. PubMed ID: 31054970
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypertrichosis around a leg ulcer being treated with prostaglandin E1 ointment.
    Honda T; Koreeda S; Miyachi Y; Kabashima K
    J Am Acad Dermatol; 2011 Jun; 64(6):1212-3. PubMed ID: 21571200
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss.
    Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Gil-Redondo R; Ortega-Quijano D; Fernandez-Nieto D; Jaen-Olasolo P; Vaño-Galvan S
    J Am Acad Dermatol; 2021 Jan; 84(1):222-223. PubMed ID: 32926970
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-induced excess hair growth.
    Prescrire Int; 2017 May; 26(182):122-124. PubMed ID: 30730670
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diffuse hypertrichosis caused by minoxidil in a 2-and-a-half-year-old child].
    Lorette G; Nivet H
    Ann Dermatol Venereol; 1985; 112(6-7):527-8. PubMed ID: 4073748
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe hypertrichosis of the external ear canal during minoxidil therapy.
    Toriumi DM; Konior RJ; Berktold RE
    Arch Otolaryngol Head Neck Surg; 1988 Aug; 114(8):918-9. PubMed ID: 3390339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
    Hagemann T; Schlütter-Böhmer B; Allam JP; Bieber T; Novak N
    Contact Dermatitis; 2005 Jul; 53(1):53-5. PubMed ID: 15982234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extreme caudal agenesis. Possible drug-related etiology?
    Rojansky N; Fasouliotis SJ; Ariel I; Nadjari M
    J Reprod Med; 2002 Mar; 47(3):241-5. PubMed ID: 11933692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
    Hoedemaker C; van Egmond S; Sinclair R
    Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal toxic epidermal necrolysis associated with minoxidil.
    Karaoui LR; Chahine-Chakhtoura C
    Pharmacotherapy; 2009 Apr; 29(4):460-7. PubMed ID: 19323621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pustular allergic contact dermatitis from topical minoxidil 5%.
    Rodríguez-Martín M; Sáez-Rodríguez M; Carnerero-Rodríguez A; Cabrera de Paz R; Sidro-Sarto M; Pérez-Robayna N; Guimerá F; Sánchez R; García-Bustínduy M; Noda-Cabrera A
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):701-2. PubMed ID: 17447999
    [No Abstract]   [Full Text] [Related]  

  • 35. Short and curly.
    Dey R; Donald TG
    Med J Aust; 2000 Jan; 172(1):48. PubMed ID: 10682029
    [No Abstract]   [Full Text] [Related]  

  • 36. Vacuum constriction device and topical minoxidil for management of impotence.
    Cecchi M; Sepich CA; Felipetto R; Vigano L; Pagni G; Minervini R; Fiorentini L
    Arch Esp Urol; 1995 Dec; 48(10):1058-9. PubMed ID: 8588728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porphyria mimicked during minoxidil therapy.
    Wilkin JK; Kirkendall WM
    Cutis; 1983 Jan; 31(1):61-2, 64. PubMed ID: 6825460
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring.
    Sanabria BD; Perdomo YC; Miot HA; Ramos PM
    An Bras Dermatol; 2024; 99(5):734-736. PubMed ID: 38772752
    [No Abstract]   [Full Text] [Related]  

  • 39. Limited use of minoxidil in renal transplant recipients because of the additive side-effects of cyclosporine on hypertrichosis.
    Sever MS; Sonmez YE; Kocak N
    Transplantation; 1990 Sep; 50(3):536. PubMed ID: 2402807
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical minoxidil for baldness: a reappraisal.
    Med Lett Drugs Ther; 1994 Jan; 36(914):9-10. PubMed ID: 8277913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.